Table 4
Summary of results
| Data | No (%) | Comments |
| Endoscopic access | 93 | |
| Initial data | ||
| Success | 75 (81) | |
| Surgery rate | 12 (13) | 8 due to failure, 4 due to complications |
| Complications | 24 (26) | See text |
| Mortality | 7 (7.5) | 2 during endotherapy, 5 during initial hospitalisation |
| Long-term data | ||
| Clinical success | 63 (68)* | |
| Recurrent cavity | 8 (9) | |
| Recurrent pancreatitis | 15 (16) | |
| Delayed surgery | 3 (3) | |
| Late mortality | 7 (7.5)* | One related to pancreatitis |
| Initial surgery | 12 (13) | |
| Initial surgical mortality | 1 (1) | |
| Initial mortality | 7 | |
| Bleeding | 1 | |
| Air embolism | 1 | |
| Sepsis non-surgical | 4 | |
| Postoperative (sepsis) | 1 | |
| Late mortality | ||
| For unrelated reasons | 6 | |
| Related to pancreas† | 1 |
-
*Six out of seven patients who died during follow-up were counted as having had initially successful pancreatic endotherapy (see table 2).
-
†Including endotherapy or surgery.
